[HTML][HTML] The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
The global epidemiology of nonalcoholic fatty liver disease... : Hepatology The global
epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) …
epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) …
The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis
Background Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease
worldwide and the leading cause of liver-related morbidity and mortality. We aimed to …
worldwide and the leading cause of liver-related morbidity and mortality. We aimed to …
Global incidence and prevalence of nonalcoholic fatty liver disease
MLP Teng, CH Ng, DQ Huang, KE Chan… - Clinical and …, 2022 - pmc.ncbi.nlm.nih.gov
Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease worldwide. The
estimated global incidence of NAFLD is 47 cases per 1,000 population and is higher among …
estimated global incidence of NAFLD is 47 cases per 1,000 population and is higher among …
Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer
Liver cancer epidemiology is changing due to increasing alcohol consumption, rising
prevalence of obesity, and advances in hepatitis B virus (HBV) and hepatitis C virus (HCV) …
prevalence of obesity, and advances in hepatitis B virus (HBV) and hepatitis C virus (HCV) …
Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta …
J Quek, KE Chan, ZY Wong, C Tan, B Tan… - The lancet …, 2023 - thelancet.com
Background The global burden of non-alcoholic fatty liver disease (NAFLD) parallels the
increase in obesity rates across the world. Although overweight and obesity status are …
increase in obesity rates across the world. Although overweight and obesity status are …
Global burden of hepatitis B virus: current status, missed opportunities and a call for action
Chronic hepatitis B virus (HBV) infection affects about 296 million people worldwide and is
the leading aetiology of cirrhosis and liver cancer globally. Major medical complications also …
the leading aetiology of cirrhosis and liver cancer globally. Major medical complications also …
[HTML][HTML] Changing epidemiology, global trends and implications for outcomes of NAFLD
Non-alcoholic fatty liver disease (NAFLD) has rapidly become the most common liver
disease globally and is currently estimated to affect 38% of the global population. Only a …
disease globally and is currently estimated to affect 38% of the global population. Only a …
Lifestyle interventions in nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is a dynamic chronic liver disease that develops in
close association with metabolic irregularities. Between 2016 and 2019, the global …
close association with metabolic irregularities. Between 2016 and 2019, the global …
Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease
Recompensation has gained increasing attention in the field of cirrhosis, particularly in
chronic liver disease with a definite aetiology. The current global prevalence of obesity and …
chronic liver disease with a definite aetiology. The current global prevalence of obesity and …
Global prevalence and clinical characteristics of metabolic-associated fatty liver disease: a meta-analysis and systematic review of 10 739 607 individuals
KE Chan, TJL Koh, ASP Tang, J Quek… - The Journal of …, 2022 - academic.oup.com
Abstract Background and Aims Metabolic-associated fatty liver disease (MAFLD) was
proposed as a better definition of nonalcoholic fatty liver disease (NAFLD) to encompass the …
proposed as a better definition of nonalcoholic fatty liver disease (NAFLD) to encompass the …